PT1368016E - Formas de dosagem parenterica que compreendem uma suspensao de sal de tramadol e sal de diclofenac - Google Patents
Formas de dosagem parenterica que compreendem uma suspensao de sal de tramadol e sal de diclofenacInfo
- Publication number
- PT1368016E PT1368016E PT01994735T PT01994735T PT1368016E PT 1368016 E PT1368016 E PT 1368016E PT 01994735 T PT01994735 T PT 01994735T PT 01994735 T PT01994735 T PT 01994735T PT 1368016 E PT1368016 E PT 1368016E
- Authority
- PT
- Portugal
- Prior art keywords
- salt
- suspension
- parenteric
- dosage
- understand
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10059020A DE10059020A1 (de) | 2000-11-28 | 2000-11-28 | Parenteral applizierbare Darreichungsformen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1368016E true PT1368016E (pt) | 2006-08-31 |
Family
ID=7664956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01994735T PT1368016E (pt) | 2000-11-28 | 2001-11-27 | Formas de dosagem parenterica que compreendem uma suspensao de sal de tramadol e sal de diclofenac |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6875447B2 (pt) |
| EP (1) | EP1368016B1 (pt) |
| JP (1) | JP4188084B2 (pt) |
| CN (1) | CN100384410C (pt) |
| AT (1) | ATE323477T1 (pt) |
| AU (1) | AU2002224896A1 (pt) |
| CY (1) | CY1105625T1 (pt) |
| DE (2) | DE10059020A1 (pt) |
| DK (1) | DK1368016T3 (pt) |
| ES (1) | ES2262703T3 (pt) |
| PT (1) | PT1368016E (pt) |
| WO (1) | WO2002043723A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007023205A1 (en) * | 2005-08-24 | 2007-03-01 | Telechemistry Oy | A method of testing a liquid sample, a test unit, and an automized system of a plurality of test units |
| WO2008093686A1 (ja) | 2007-01-29 | 2008-08-07 | Medrx Co., Ltd. | 非ステロイド系抗炎症薬と有機アミン化合物との塩とその用途 |
| AU2013204763B2 (en) * | 2008-01-14 | 2015-06-04 | Biokit, S.A. | Device for distributing particles in a fluid and methods therefor |
| US8182762B2 (en) * | 2008-01-14 | 2012-05-22 | Biokit, S.A. | Device for distributing particles in a fluid and methods thereof |
| EP2281558A1 (en) * | 2009-08-06 | 2011-02-09 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical compounds of O-Desmethyl-Tramadol and COX-inhibitors |
| EP2593096A4 (en) * | 2010-07-12 | 2014-02-26 | Yung Shin Pharm Ind Co Ltd | DICLOFENAC SALT OF TRAMADOL |
| US8895622B2 (en) | 2011-04-12 | 2014-11-25 | Revogenex Ireland Ltd. | Intravenous administration of tramadol |
| US9980900B2 (en) | 2015-12-22 | 2018-05-29 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
| US9693949B1 (en) | 2015-12-22 | 2017-07-04 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
| US10022321B2 (en) | 2016-06-30 | 2018-07-17 | Revogenex Ireland Ltd. | Intravenous administration of tramadol |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4016273A (en) * | 1975-07-16 | 1977-04-05 | American Cyanamid Company | Sustained release forms of certain oxazepines for parenteral administration |
| DE3324193A1 (de) * | 1983-07-05 | 1985-01-17 | Troponwerke Gmbh & Co Kg | Depot-antiphlogistika |
| US5283067A (en) * | 1987-01-30 | 1994-02-01 | Ciba-Geigy Corporation | Parenteral suspensions |
| DK0566709T5 (da) * | 1991-09-06 | 2009-05-18 | Ortho Mcneil Janssen Pharm | Præparat indeholdende et tramadolmateriale og acetaminophen og anvendelse deraf |
| AU661723B2 (en) * | 1991-10-30 | 1995-08-03 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| US5594091A (en) * | 1994-02-21 | 1997-01-14 | Takeda Chemical Industries, Ltd. | Matrix for sustained-release preparation |
| ATE223202T1 (de) * | 1994-09-30 | 2002-09-15 | Mika Pharma Ges Fuer Die Entwi | Pharmazeutische zusammensetzung |
| AU7472798A (en) * | 1997-05-07 | 1998-11-27 | Algos Pharmaceutical Corporation | Cox-2 inhibitors in combination with nmda-blockers for treating pain |
| DE19732928C2 (de) * | 1997-07-31 | 2000-05-18 | Gruenenthal Gmbh | Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel |
| WO2000029022A1 (en) * | 1998-11-12 | 2000-05-25 | Algos Pharmaceutical Corporation | Cox-2 inhibitors in combination with centrally acting analgesics |
| JP2002538078A (ja) * | 1998-11-12 | 2002-11-12 | アルゴス ファーマシューティカル コーポレーション | 痛みを治療するnmda−ブロッカーと組み合わされたcox−2阻害剤 |
| EP1180020B2 (en) * | 1999-05-27 | 2009-06-24 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
-
2000
- 2000-11-28 DE DE10059020A patent/DE10059020A1/de not_active Withdrawn
-
2001
- 2001-11-27 JP JP2002545694A patent/JP4188084B2/ja not_active Expired - Fee Related
- 2001-11-27 ES ES01994735T patent/ES2262703T3/es not_active Expired - Lifetime
- 2001-11-27 CN CNB018196829A patent/CN100384410C/zh not_active Expired - Fee Related
- 2001-11-27 AU AU2002224896A patent/AU2002224896A1/en not_active Abandoned
- 2001-11-27 DE DE50109572T patent/DE50109572D1/de not_active Expired - Lifetime
- 2001-11-27 WO PCT/EP2001/013789 patent/WO2002043723A1/de not_active Ceased
- 2001-11-27 PT PT01994735T patent/PT1368016E/pt unknown
- 2001-11-27 DK DK01994735T patent/DK1368016T3/da active
- 2001-11-27 EP EP01994735A patent/EP1368016B1/de not_active Expired - Lifetime
- 2001-11-27 AT AT01994735T patent/ATE323477T1/de active
-
2003
- 2003-05-21 US US10/442,701 patent/US6875447B2/en not_active Expired - Fee Related
-
2006
- 2006-06-26 CY CY20061100859T patent/CY1105625T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4188084B2 (ja) | 2008-11-26 |
| US20030203037A1 (en) | 2003-10-30 |
| DE10059020A1 (de) | 2002-05-29 |
| JP2004514692A (ja) | 2004-05-20 |
| CY1105625T1 (el) | 2010-12-22 |
| US6875447B2 (en) | 2005-04-05 |
| WO2002043723A1 (de) | 2002-06-06 |
| CN1477955A (zh) | 2004-02-25 |
| EP1368016A1 (de) | 2003-12-10 |
| ES2262703T3 (es) | 2006-12-01 |
| CN100384410C (zh) | 2008-04-30 |
| AU2002224896A1 (en) | 2002-06-11 |
| EP1368016B1 (de) | 2006-04-19 |
| ATE323477T1 (de) | 2006-05-15 |
| DE50109572D1 (de) | 2006-05-24 |
| DK1368016T3 (da) | 2006-07-31 |
| HK1060971A1 (en) | 2004-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27940A1 (es) | Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a | |
| HN2002000030A (es) | Nueva sal succinato de o-desmetil-venlafaxina | |
| AR046970A1 (es) | Esteres de fosfato de florfenicol | |
| ATE514418T1 (de) | Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan | |
| NO20054681L (no) | Farmasoytiske produkter | |
| ECSP024341A (es) | Composiciones farmaceuticas | |
| DK0840606T3 (da) | Små di- og trivalente molekyler som selectininhibitorer | |
| MXPA04002009A (es) | Composicion farmaceutica que comprende gabapentina o un analogo de la misma y alfa-aminoamida y su uso como analgesico. | |
| MA27115A1 (fr) | Sel de perindopril et les compositions pharmaceutiques qui les contiennent | |
| PT1368016E (pt) | Formas de dosagem parenterica que compreendem uma suspensao de sal de tramadol e sal de diclofenac | |
| ATE432068T1 (de) | Cetirizin und pseudoephedrin enthaltende tablette | |
| MX2007000117A (es) | Una composicion de combinacion. | |
| BRPI0410044B8 (pt) | forma de dosagem contendo pantoprazol como ingrediente ativo | |
| DK1353948T3 (da) | Oplöselige biologiske analoge til bata-amyloidpeptid | |
| HRP20031057B1 (hr) | Tableta koja sadrži cetirizin i pseudoefedrin | |
| IS6087A (is) | N-(2-fenýl-4-amínó-bútýl)-1-naftamíð sem virka á móti taugakínín-1 viðtaka | |
| EA200800698A1 (ru) | Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы | |
| BRPI0417265A (pt) | composição farmacêutica compreendendo um princìpio ativo e sulfobetaìna | |
| EA200300639A1 (ru) | Применение sarp-1 для лечения и/или предупреждения склеродермии | |
| AR042037A1 (es) | Profarmaco de celecoxib | |
| GT200400183A (es) | Formas de dosificacion de azitromicina con efectos secundarios reducidos | |
| SE0203817D0 (sv) | New composition | |
| ATE402703T1 (de) | Tablette enthaltend efletirizin und pseudoephedrin | |
| BRPI0414423A (pt) | inibidores de pace4, suas composições farmacêuticas e respectivos usos | |
| GEP20084546B (en) | Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent |